{"entity":{"type":"insider","cik":"0001663021","url":"/insider/0001663021","json_url":"/insider/0001663021.json","name":"Hall Justin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2019-10-28","last":"2022-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Hall Justin","source":"filing","n_filings":3,"first_seen":"2019-10-28","last_seen":"2022-09-16"}],"transactions":[{"id":6601315,"accession":"0001437749-22-022651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-022651","line_url":"/filing/0001437749-22-022651#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001663021","owner_name":"Hall Justin","owner_display_name":"Hall Justin","owner_url":"/insider/0001663021","role":"Director, Officer (CEO, GC and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, GC and Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":83172.0,"shares_owned_after_display":"83,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-16","scope":"insider"},{"id":4633983,"accession":"0001437749-21-027958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-027958","line_url":"/filing/0001437749-21-027958#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001663021","owner_name":"Hall Justin","owner_display_name":"Hall Justin","owner_url":"/insider/0001663021","role":"Director, Officer (CEO, GC and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, GC and Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69767.0,"shares_display":"69,767","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":29999.81,"total_display":"29,999.81","total_whole":"30,000","shares_owned_after":73172.0,"shares_owned_after_display":"73,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-06","scope":"insider"},{"id":9288169,"accession":"0001437749-19-020744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-020744","line_url":"/filing/0001437749-19-020744#line-1","is_derivative":false,"issuer_cik":"0001663021","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001663021","owner_cik":"0001663021","owner_name":"Hall Justin","owner_display_name":"Hall Justin","owner_url":"/insider/0001663021","role":"Officer (Interim President & CEO and GC)","role_mark":"O","role_mark_label":"Officer (Interim President & CEO and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim President & CEO and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47500.0,"shares_display":"47,500","price_per_share":3.03,"price_display":"3.03","price_state":"stated","total_value":143925.0,"total_display":"143,925.00","total_whole":"143,925","shares_owned_after":3405.0,"shares_owned_after_display":"3,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-10-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001389545","name":"NovaBay Pharmaceuticals, Inc.","url":"/issuer/0001389545","role":"Director, Officer (CEO, GC and Director)","n_filings":3,"first_seen":"2019-10-28","last_seen":"2022-09-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001663021","retrieved_at":"2026-08-27T17:07:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}